| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aldosterone-receptor antagonism and end-stage renal disease
|
McLaughlin, Niall
|
|
2004
|
6 |
4 |
p. 327-330
|
article
|
| 2 |
Angiotensin II: An amplifier of cardiovascular risk
|
Volpe, Massimo
|
|
2004
|
6 |
4 |
p. 247-248
|
article
|
| 3 |
Are angiotensin receptor blockers neuroprotective?
|
Thöne-Reineke, Christa
|
|
2004
|
6 |
4 |
p. 257-266
|
article
|
| 4 |
Clinical Trials Report
|
Weber, Michael A.
|
|
2004
|
6 |
4 |
p. 291-292
|
article
|
| 5 |
Clinical Trials Report
|
Siragy, Helmy M.
|
|
2004
|
6 |
4 |
p. 255-256
|
article
|
| 6 |
Combination therapy as first-line treatment for hypertension
|
Gavras, Irene
|
|
2004
|
6 |
4 |
p. 267-272
|
article
|
| 7 |
Combined antihypertensive and lipid-lowering treatment
|
Cesari, Maurizio
|
|
2004
|
6 |
4 |
p. 300-306
|
article
|
| 8 |
Compelling drug indications in diabetic and nondiabetic nephropathy
|
Ritz, Eberhard
|
|
2004
|
6 |
4 |
p. 293-299
|
article
|
| 9 |
Hypertension management in patients with diabetic nephropathy
|
McCall, Anthony L.
|
|
2004
|
6 |
4 |
p. 272-279
|
article
|
| 10 |
Lead-induced hypertension: Role of oxidative stress
|
Vaziri, Nosratola D.
|
|
2004
|
6 |
4 |
p. 314-320
|
article
|
| 11 |
Literature alert
|
|
|
2004
|
6 |
4 |
p. 251-252
|
article
|
| 12 |
Mineralocorticoid receptor antagonists and hypertension: Is there a rationale?
|
Gumieniak, Olga
|
|
2004
|
6 |
4 |
p. 279-287
|
article
|
| 13 |
Protection against stroke and dementia: An update on the latest clinical trial evidence
|
Williams, Bryan
|
|
2004
|
6 |
4 |
p. 307-313
|
article
|
| 14 |
The relationship between exposure to violence and blood pressure mechanisms
|
Wilson, Dawn K.
|
|
2004
|
6 |
4 |
p. 321-326
|
article
|
| 15 |
Web alert
|
|
|
2004
|
6 |
4 |
p. 249-250
|
article
|
Journal description